Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
281 studies found for:    pharmacology + NICHD
Show Display Options
Rank Status Study
21 Completed Melatonin for Sleep in Children With Autism
Conditions: Autistic Disorder;   Insomnia
Interventions: Drug: supplemental liquid melatonin;   Drug: flavored liquid or liquid supplemental melatonin
22 Completed NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
Conditions: Asthma;   Lung Diseases
Interventions: Drug: theophylline;   Drug: beclomethasone
23 Completed Vitamin E for Extremely Preterm Infants
Conditions: Infant, Newborn;   Infant, Small for Gestational Age;   Infant, Very Low Birth Weight;   Infant, Premature;   Intracranial Hemorrhages
Interventions: Drug: Vitamin E;   Drug: Placebo
24 Completed Early Blood Pressure Management in Extremely Premature Infants
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Hypotension;   Blood Pressure
Interventions: Drug: Dopamine;   Drug: Hydrocortisone;   Drug: Infusion Placebo;   Drug: Syringe Placebo
25 Completed Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Bronchopulmonary Dysplasia;   Respiration, Artificial;   Respiratory Distress Syndrome, Newborn;   Sepsis
Interventions: Drug: Vitamin A;   Other: Sham Procedure
26 Completed Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight
Conditions: Hyperbilirubinemia, Neonatal;   Jaundice, Neonatal;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Aggressive Phototherapy 501-750g;   Procedure: Aggressive Phototherapy 751-1000g;   Procedure: Conservative Phototherapy 501-750g;   Procedure: Conservative Phototherapy 751-1000g
27 Terminated Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Respiratory Distress Syndrome (RDS);   Sepsis;   Pneumonia;   Hypertension, Pulmonary
Interventions: Drug: Inhaled nitric oxide;   Drug: Placebo
28 Completed Dexamethasone Therapy in VLBW Infants at Risk of CLD
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Bronchopulmonary Dysplasia
Interventions: Drug: Dexamethasone Early;   Drug: Dexamethasone Late
29 Completed Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Intracranial Hemorrhages
Interventions: Drug: Phenobarbital;   Drug: Saline
30 Terminated Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
Conditions: Bronchopulmonary Dysplasia;   Respiratory Distress Syndrome;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Minimal mechanical ventilation management;   Procedure: Routine mechanical ventilation management;   Drug: Dexamethasone;   Drug: Placebo
31 Terminated Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
Conditions: Infant, Newborn;   Hypertension, Pulmonary;   Persistent Fetal Circulation Syndrome;   Pneumonia, Aspiration;   Respiratory Distress Syndrome, Newborn;   Respiratory Insufficiency
Interventions: Drug: Inhaled nitric oxide;   Drug: Placebo
32 Terminated Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
Conditions: Infant, Newborn;   Hypertension, Pulmonary;   Persistent Fetal Circulation Syndrome;   Pneumonia, Aspiration;   Respiratory Distress Syndrome, Newborn;   Respiratory Insufficiency
Interventions: Drug: Inhaled Nitric Oxide;   Drug: Standard iNO therapy
33 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
34 Completed Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Conditions: Bacterial Infections;   Obesity
Intervention: Drug: Clindamycin
35 Completed rhGH Therapy on Hepatic Drug Metabolism
Condition: Growth Hormone Deficiency, Dwarfism
Intervention: Drug: Dextromethorphan and Caffeine
36 Completed Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)
Condition: Brain Injury
Interventions: Drug: Methylphenidate;   Behavioral: Memory and Attention Training;   Other: Placebo as both treatments
37 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
38 Completed Fluconazole Pharmacokinetics in Infants
Condition: Fungal Infection
Intervention:
39 Completed Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
Condition: Urinary Incontinence, Urge
Interventions: Device: InterStim® device;   Drug: Botox® injection
40 Completed Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)
Condition: Systemic Infection
Intervention: Drug: Antibiotic

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years